Research spanning more than 20 years has led the UPV/EHU's Neurochemistry and Neurodegeneration group under Dr. Rafael Rodríguez-Puertas to discover a promising avenue for the development of new ...

A recent study is showing a potential link between a common infection and the development of Alzheimer’s disease. Researchers ...

A striking 81% of participants with probable dementia were unaware of their diagnosis, with Mexican American participants ...

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Dartmouth Health is the only health care system on the East Coast to be part of the newly launched Brain Health Navigator ...

SPRINGFIELD - The Smith Alzheimer’s Center at SIU Medicine is offering two new lab internship opportunities for undergraduate ...

Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...

Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...

A new study found that dementia cases in the United States are projected to double from more than 500,000 in 2020 to about 1 ...